Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

992 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma.
Sabbatino F, Scognamiglio G, Liguori L, Marra A, Anniciello AM, Polcaro G, Dal Col J, Caputo A, Peluso AL, Botti G, Zeppa P, Ferrone S, Pepe S. Sabbatino F, et al. Among authors: marra a. Front Immunol. 2020 Sep 29;11:561390. doi: 10.3389/fimmu.2020.561390. eCollection 2020. Front Immunol. 2020. PMID: 33117345 Free PMC article.
Immune Checkpoint Inhibitors in Melanoma and HIV Infection.
Marra A, Scognamiglio G, Peluso I, Botti G, Fusciello C, Filippelli A, Ascierto PA, Pepe S, Sabbatino F. Marra A, et al. Open AIDS J. 2017 Nov 14;11:91-100. doi: 10.2174/1874613601711010091. eCollection 2017. Open AIDS J. 2017. PMID: 29290886 Free PMC article. Review.
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis.
Esposito A, Marra A, Bagnardi V, Frassoni S, Morganti S, Viale G, Zagami P, Varano GM, Buccimazza G, Orsi F, Venetis K, Mazzarella L, Viale G, Fusco N, Criscitiello C, Curigliano G. Esposito A, et al. Among authors: marra a. Eur J Cancer. 2021 Mar;145:197-209. doi: 10.1016/j.ejca.2020.12.028. Epub 2021 Jan 22. Eur J Cancer. 2021. PMID: 33493979
What therapies are on the horizon for HER2 positive breast cancer?
Viale G, Morganti S, Ferraro E, Zagami P, Marra A, Curigliano G. Viale G, et al. Among authors: marra a. Expert Rev Anticancer Ther. 2019 Sep;19(9):811-822. doi: 10.1080/14737140.2019.1660164. Epub 2019 Aug 28. Expert Rev Anticancer Ther. 2019. PMID: 31448640 Review.
Evolution of low HER2 expression between early and advanced-stage breast cancer.
Tarantino P, Gandini S, Nicolò E, Trillo P, Giugliano F, Zagami P, Vivanet G, Bellerba F, Trapani D, Marra A, Esposito A, Criscitiello C, Viale G, Curigliano G. Tarantino P, et al. Among authors: marra a. Eur J Cancer. 2022 Mar;163:35-43. doi: 10.1016/j.ejca.2021.12.022. Epub 2022 Jan 13. Eur J Cancer. 2022. PMID: 35032815
992 results